F-star Therapeutics, Inc. Free Cash Flow 2016-2022 | FSTX
F-star Therapeutics, Inc. free cash flow from 2016 to 2022. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| F-star Therapeutics, Inc. Annual Free Cash Flow |
| 2021 |
-27.91 |
| 2020 |
-16.23 |
| 2019 |
-22.11 |
| 2018 |
-27.22 |
| 2017 |
-18.01 |
| 2016 |
-16.03 |
| 2015 |
-8.60 |
| 2014 |
-7.43 |
| F-star Therapeutics, Inc. Quarterly Free Cash Flow |
| 2022-09-30 |
-44.94 |
| 2022-06-30 |
-28.38 |
| 2022-03-31 |
-11.62 |
| 2021-12-31 |
-27.91 |
| 2021-09-30 |
-34.69 |
| 2021-06-30 |
-23.99 |
| 2021-03-31 |
-14.63 |
| 2020-12-31 |
-16.23 |
| 2020-09-30 |
-0.12 |
| 2020-06-30 |
-2.54 |
| 2020-03-31 |
-1.52 |
| 2019-12-31 |
-22.11 |
| 2019-09-30 |
-20.68 |
| 2019-06-30 |
-14.97 |
| 2019-03-31 |
-6.86 |
| 2018-12-31 |
-27.22 |
| 2018-09-30 |
-20.27 |
| 2018-06-30 |
-13.95 |
| 2018-03-31 |
-6.44 |
| 2017-12-31 |
-18.01 |
| 2017-09-30 |
-12.77 |
| 2017-06-30 |
-8.87 |
| 2017-03-31 |
-4.22 |
| 2016-12-31 |
-16.03 |
| 2016-09-30 |
-11.86 |
| 2016-06-30 |
-9.05 |
| 2016-03-31 |
-4.71 |
| 2015-12-31 |
-8.60 |
| 2015-09-30 |
-6.67 |
| 2015-06-30 |
-4.01 |
| 2015-03-31 |
-1.75 |
